Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Stanford University
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Samuel Strober, Stanford University
ClinicalTrials.gov Identifier:
NCT00319657
First received: April 28, 2006
Last updated: August 11, 2016
Last verified: August 2016